nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ABCB1—adrenal gland cancer	0.504	1	CbGaD
Dipyridamole—PDE5A—clitoris—adrenal gland cancer	0.0425	0.216	CbGeAlD
Dipyridamole—PDE3B—brown adipose tissue—adrenal gland cancer	0.0201	0.103	CbGeAlD
Dipyridamole—ADA—brown adipose tissue—adrenal gland cancer	0.0153	0.0777	CbGeAlD
Dipyridamole—PDE6A—pituitary gland—adrenal gland cancer	0.00806	0.0411	CbGeAlD
Dipyridamole—PRUNE—cardiac atrium—adrenal gland cancer	0.00522	0.0266	CbGeAlD
Dipyridamole—PRUNE—pituitary gland—adrenal gland cancer	0.0051	0.026	CbGeAlD
Dipyridamole—PDE1C—adrenal gland—adrenal gland cancer	0.00505	0.0257	CbGeAlD
Dipyridamole—PRUNE—adrenal gland—adrenal gland cancer	0.00456	0.0232	CbGeAlD
Dipyridamole—PDE6D—adrenal gland—adrenal gland cancer	0.0044	0.0224	CbGeAlD
Dipyridamole—PDE6B—adrenal gland—adrenal gland cancer	0.00433	0.0221	CbGeAlD
Dipyridamole—PDE11A—adrenal gland—adrenal gland cancer	0.00403	0.0205	CbGeAlD
Dipyridamole—PDE6G—adrenal gland—adrenal gland cancer	0.00387	0.0197	CbGeAlD
Dipyridamole—PDE2A—adrenal cortex—adrenal gland cancer	0.00363	0.0185	CbGeAlD
Dipyridamole—PDE7B—adrenal gland—adrenal gland cancer	0.00314	0.016	CbGeAlD
Dipyridamole—PDE8A—adrenal cortex—adrenal gland cancer	0.00311	0.0158	CbGeAlD
Dipyridamole—PDE2A—cardiac atrium—adrenal gland cancer	0.003	0.0153	CbGeAlD
Dipyridamole—PDE1B—gonad—adrenal gland cancer	0.00298	0.0152	CbGeAlD
Dipyridamole—PDE2A—pituitary gland—adrenal gland cancer	0.00293	0.0149	CbGeAlD
Dipyridamole—PDE8B—gonad—adrenal gland cancer	0.00286	0.0146	CbGeAlD
Dipyridamole—PDE3B—pituitary gland—adrenal gland cancer	0.00273	0.0139	CbGeAlD
Dipyridamole—PDE2A—adrenal gland—adrenal gland cancer	0.00262	0.0133	CbGeAlD
Dipyridamole—PDE10A—adrenal gland—adrenal gland cancer	0.00262	0.0133	CbGeAlD
Dipyridamole—PDE1B—adrenal gland—adrenal gland cancer	0.00259	0.0132	CbGeAlD
Dipyridamole—PDE8A—cardiac atrium—adrenal gland cancer	0.00257	0.0131	CbGeAlD
Dipyridamole—PDE8A—pituitary gland—adrenal gland cancer	0.00251	0.0128	CbGeAlD
Dipyridamole—PDE8B—adrenal gland—adrenal gland cancer	0.0025	0.0127	CbGeAlD
Dipyridamole—PDE1A—gonad—adrenal gland cancer	0.00249	0.0127	CbGeAlD
Dipyridamole—PDE3B—adrenal gland—adrenal gland cancer	0.00244	0.0124	CbGeAlD
Dipyridamole—PDE8A—adrenal gland—adrenal gland cancer	0.00225	0.0114	CbGeAlD
Dipyridamole—PDE1A—adrenal gland—adrenal gland cancer	0.00217	0.0111	CbGeAlD
Dipyridamole—ADA—adrenal gland—adrenal gland cancer	0.00185	0.00941	CbGeAlD
Dipyridamole—PDE4A—adrenal gland—adrenal gland cancer	0.0018	0.00917	CbGeAlD
Dipyridamole—SLC29A1—adrenal cortex—adrenal gland cancer	0.00178	0.00907	CbGeAlD
Dipyridamole—PDE5A—gonad—adrenal gland cancer	0.00176	0.00895	CbGeAlD
Dipyridamole—PDE3A—cardiac atrium—adrenal gland cancer	0.00171	0.00869	CbGeAlD
Dipyridamole—ABCC5—cardiac atrium—adrenal gland cancer	0.0016	0.00817	CbGeAlD
Dipyridamole—ABCC5—pituitary gland—adrenal gland cancer	0.00157	0.00799	CbGeAlD
Dipyridamole—PDE5A—adrenal gland—adrenal gland cancer	0.00153	0.0078	CbGeAlD
Dipyridamole—PDE3A—adrenal gland—adrenal gland cancer	0.00149	0.00759	CbGeAlD
Dipyridamole—SLC29A1—gonad—adrenal gland cancer	0.00148	0.00751	CbGeAlD
Dipyridamole—SLC29A1—cardiac atrium—adrenal gland cancer	0.00147	0.0075	CbGeAlD
Dipyridamole—SLC29A1—pituitary gland—adrenal gland cancer	0.00144	0.00733	CbGeAlD
Dipyridamole—ABCC5—adrenal gland—adrenal gland cancer	0.0014	0.00713	CbGeAlD
Dipyridamole—SLC29A1—adrenal gland—adrenal gland cancer	0.00129	0.00655	CbGeAlD
Dipyridamole—ABCC4—adrenal gland—adrenal gland cancer	0.000971	0.00494	CbGeAlD
Dipyridamole—ABCB1—adrenal cortex—adrenal gland cancer	0.000468	0.00238	CbGeAlD
Dipyridamole—ABCB1—gonad—adrenal gland cancer	0.000388	0.00197	CbGeAlD
Dipyridamole—ABCB1—pituitary gland—adrenal gland cancer	0.000378	0.00193	CbGeAlD
Dipyridamole—ABCB1—adrenal gland—adrenal gland cancer	0.000338	0.00172	CbGeAlD
Dipyridamole—PDE3A—Signaling by GPCR—GNAS—adrenal gland cancer	7.97e-05	0.000266	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—BAD—adrenal gland cancer	7.9e-05	0.000263	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—BAD—adrenal gland cancer	7.9e-05	0.000263	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—CDC42—adrenal gland cancer	7.9e-05	0.000263	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—BRAF—adrenal gland cancer	7.89e-05	0.000263	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—BAD—adrenal gland cancer	7.85e-05	0.000262	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by NGF—EGFR—adrenal gland cancer	7.84e-05	0.000262	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—CDC42—adrenal gland cancer	7.84e-05	0.000261	CbGpPWpGaD
Dipyridamole—ABCC4—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	7.83e-05	0.000261	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MEN1—adrenal gland cancer	7.82e-05	0.000261	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SPRY2—adrenal gland cancer	7.81e-05	0.00026	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—GNRH1—adrenal gland cancer	7.81e-05	0.00026	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PRKACA—adrenal gland cancer	7.8e-05	0.00026	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PRKACA—adrenal gland cancer	7.8e-05	0.00026	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IGF1R—adrenal gland cancer	7.79e-05	0.00026	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—BRAF—adrenal gland cancer	7.78e-05	0.000259	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—PRKACA—adrenal gland cancer	7.72e-05	0.000258	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—BAD—adrenal gland cancer	7.7e-05	0.000257	CbGpPWpGaD
Dipyridamole—ABCC4—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	7.69e-05	0.000256	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MEN1—adrenal gland cancer	7.61e-05	0.000254	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TSHR—adrenal gland cancer	7.61e-05	0.000254	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—GNAS—adrenal gland cancer	7.55e-05	0.000252	CbGpPWpGaD
Dipyridamole—PDE5A—Hemostasis—TP53—adrenal gland cancer	7.53e-05	0.000251	CbGpPWpGaD
Dipyridamole—PDE10A—Hemostasis—TP53—adrenal gland cancer	7.53e-05	0.000251	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TERT—adrenal gland cancer	7.52e-05	0.000251	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TERT—adrenal gland cancer	7.52e-05	0.000251	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—GNAS—adrenal gland cancer	7.49e-05	0.00025	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—GNAS—adrenal gland cancer	7.28e-05	0.000243	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—POMC—adrenal gland cancer	7.28e-05	0.000243	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—POMC—adrenal gland cancer	7.28e-05	0.000243	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—BRAF—adrenal gland cancer	7.19e-05	0.00024	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—BRAF—adrenal gland cancer	7.19e-05	0.00024	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by NGF—EGFR—adrenal gland cancer	7.17e-05	0.000239	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CDC42—adrenal gland cancer	7.17e-05	0.000239	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CDC42—adrenal gland cancer	7.16e-05	0.000239	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MEN1—adrenal gland cancer	7.15e-05	0.000239	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—ABCB1—adrenal gland cancer	7.15e-05	0.000238	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SPRY2—adrenal gland cancer	7.14e-05	0.000238	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PRKACA—adrenal gland cancer	7.13e-05	0.000238	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—POMC—adrenal gland cancer	7.1e-05	0.000237	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—BAD—adrenal gland cancer	7.04e-05	0.000235	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—BRAF—adrenal gland cancer	7.01e-05	0.000234	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TERT—adrenal gland cancer	6.97e-05	0.000233	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—EGFR—adrenal gland cancer	6.97e-05	0.000232	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—EGFR—adrenal gland cancer	6.97e-05	0.000232	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TSHR—adrenal gland cancer	6.96e-05	0.000232	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—EGFR—adrenal gland cancer	6.91e-05	0.000231	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—EGFR—adrenal gland cancer	6.91e-05	0.000231	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TERT—adrenal gland cancer	6.88e-05	0.000229	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—GNAS—adrenal gland cancer	6.85e-05	0.000228	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—EGFR—adrenal gland cancer	6.79e-05	0.000226	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TERT—adrenal gland cancer	6.71e-05	0.000224	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CDC42—adrenal gland cancer	6.61e-05	0.000221	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CDC42—adrenal gland cancer	6.61e-05	0.000221	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CDC42—adrenal gland cancer	6.55e-05	0.000218	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—BAD—adrenal gland cancer	6.54e-05	0.000218	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—BAD—adrenal gland cancer	6.54e-05	0.000218	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MEN1—adrenal gland cancer	6.54e-05	0.000218	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PRKACA—adrenal gland cancer	6.53e-05	0.000218	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—POMC—adrenal gland cancer	6.49e-05	0.000216	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—POMC—adrenal gland cancer	6.49e-05	0.000216	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—BRAF—adrenal gland cancer	6.41e-05	0.000214	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PRKACA—adrenal gland cancer	6.38e-05	0.000213	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—PTGS2—adrenal gland cancer	6.37e-05	0.000212	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—PTGS2—adrenal gland cancer	6.29e-05	0.00021	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—EGFR—adrenal gland cancer	6.21e-05	0.000207	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—CTNNB1—adrenal gland cancer	6.17e-05	0.000206	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—CTNNB1—adrenal gland cancer	6.11e-05	0.000204	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—CTNNB1—adrenal gland cancer	6.11e-05	0.000204	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—POMC—adrenal gland cancer	6.07e-05	0.000203	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—BAD—adrenal gland cancer	6.07e-05	0.000202	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CDC42—adrenal gland cancer	6.05e-05	0.000202	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—POMC—adrenal gland cancer	6.03e-05	0.000201	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—POMC—adrenal gland cancer	6.03e-05	0.000201	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—BAD—adrenal gland cancer	5.99e-05	0.0002	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PRKACA—adrenal gland cancer	5.97e-05	0.000199	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—BRAF—adrenal gland cancer	5.96e-05	0.000199	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—BRAF—adrenal gland cancer	5.96e-05	0.000199	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—POMC—adrenal gland cancer	5.91e-05	0.000197	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—POMC—adrenal gland cancer	5.89e-05	0.000196	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—BAD—adrenal gland cancer	5.83e-05	0.000195	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PRKACA—adrenal gland cancer	5.81e-05	0.000194	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—EGFR—adrenal gland cancer	5.77e-05	0.000193	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—EGFR—adrenal gland cancer	5.77e-05	0.000193	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	5.71e-05	0.00019	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—CTNNB1—adrenal gland cancer	5.7e-05	0.00019	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—CTNNB1—adrenal gland cancer	5.65e-05	0.000188	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—CTNNB1—adrenal gland cancer	5.62e-05	0.000188	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—POMC—adrenal gland cancer	5.59e-05	0.000187	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—POMC—adrenal gland cancer	5.55e-05	0.000185	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—BRAF—adrenal gland cancer	5.52e-05	0.000184	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—POMC—adrenal gland cancer	5.52e-05	0.000184	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—POMC—adrenal gland cancer	5.52e-05	0.000184	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PRKACA—adrenal gland cancer	5.46e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—BRAF—adrenal gland cancer	5.45e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CDC42—adrenal gland cancer	5.41e-05	0.00018	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—POMC—adrenal gland cancer	5.38e-05	0.000179	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—POMC—adrenal gland cancer	5.37e-05	0.000179	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—EGFR—adrenal gland cancer	5.35e-05	0.000179	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—BRAF—adrenal gland cancer	5.31e-05	0.000177	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TERT—adrenal gland cancer	5.31e-05	0.000177	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TERT—adrenal gland cancer	5.31e-05	0.000177	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—GNAS—adrenal gland cancer	5.29e-05	0.000176	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IGF2—adrenal gland cancer	5.21e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—CTNNB1—adrenal gland cancer	5.2e-05	0.000173	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—CTNNB1—adrenal gland cancer	5.2e-05	0.000173	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ABCB1—adrenal gland cancer	5.19e-05	0.000173	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—GNAS—adrenal gland cancer	5.17e-05	0.000172	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—CTNNB1—adrenal gland cancer	5.17e-05	0.000172	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—EGFR—adrenal gland cancer	5.15e-05	0.000172	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SDHB—adrenal gland cancer	5.12e-05	0.000171	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—POMC—adrenal gland cancer	5.08e-05	0.000169	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CDC42—adrenal gland cancer	5.06e-05	0.000169	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—CTNNB1—adrenal gland cancer	5.06e-05	0.000169	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—POMC—adrenal gland cancer	5.04e-05	0.000168	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IGF1R—adrenal gland cancer	5.04e-05	0.000168	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—BAD—adrenal gland cancer	5e-05	0.000167	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PRKACA—adrenal gland cancer	4.99e-05	0.000167	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CDC42—adrenal gland cancer	4.93e-05	0.000164	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—POMC—adrenal gland cancer	4.9e-05	0.000164	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—EGFR—adrenal gland cancer	4.89e-05	0.000163	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IGF2—adrenal gland cancer	4.88e-05	0.000163	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—TP53—adrenal gland cancer	4.87e-05	0.000162	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TERT—adrenal gland cancer	4.85e-05	0.000162	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—EGFR—adrenal gland cancer	4.84e-05	0.000161	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—EGFR—adrenal gland cancer	4.84e-05	0.000161	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—GNAS—adrenal gland cancer	4.84e-05	0.000161	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IGF2—adrenal gland cancer	4.75e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IGF1R—adrenal gland cancer	4.72e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—GNAS—adrenal gland cancer	4.71e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CDC42—adrenal gland cancer	4.63e-05	0.000154	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CTNNB1—adrenal gland cancer	4.63e-05	0.000154	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—BAD—adrenal gland cancer	4.62e-05	0.000154	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—BAD—adrenal gland cancer	4.62e-05	0.000154	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—POMC—adrenal gland cancer	4.61e-05	0.000154	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IGF1R—adrenal gland cancer	4.59e-05	0.000153	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—BAD—adrenal gland cancer	4.57e-05	0.000152	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—EGFR—adrenal gland cancer	4.52e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—EGFR—adrenal gland cancer	4.47e-05	0.000149	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IGF2—adrenal gland cancer	4.46e-05	0.000149	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—EGFR—adrenal gland cancer	4.46e-05	0.000149	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—TP53—adrenal gland cancer	4.44e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—GNAS—adrenal gland cancer	4.43e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TERT—adrenal gland cancer	4.34e-05	0.000145	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IGF1R—adrenal gland cancer	4.32e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CTNNB1—adrenal gland cancer	4.31e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CTNNB1—adrenal gland cancer	4.31e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CDC42—adrenal gland cancer	4.24e-05	0.000141	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—BAD—adrenal gland cancer	4.22e-05	0.000141	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—BRAF—adrenal gland cancer	4.2e-05	0.00014	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—BRAF—adrenal gland cancer	4.2e-05	0.00014	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	4.2e-05	0.00014	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—TP53—adrenal gland cancer	4.17e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—EGFR—adrenal gland cancer	4.12e-05	0.000137	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—EGFR—adrenal gland cancer	4.12e-05	0.000137	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—EGFR—adrenal gland cancer	4.09e-05	0.000136	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IGF2—adrenal gland cancer	4.08e-05	0.000136	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TP53—adrenal gland cancer	4.07e-05	0.000136	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TP53—adrenal gland cancer	4.07e-05	0.000136	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TERT—adrenal gland cancer	4.06e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—GNAS—adrenal gland cancer	4.05e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—EGFR—adrenal gland cancer	4.01e-05	0.000134	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CTNNB1—adrenal gland cancer	3.99e-05	0.000133	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TERT—adrenal gland cancer	3.95e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IGF1R—adrenal gland cancer	3.95e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CTNNB1—adrenal gland cancer	3.94e-05	0.000131	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PTGS2—adrenal gland cancer	3.91e-05	0.00013	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—BRAF—adrenal gland cancer	3.84e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CTNNB1—adrenal gland cancer	3.84e-05	0.000128	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.83e-05	0.000128	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TP53—adrenal gland cancer	3.82e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—BAD—adrenal gland cancer	3.77e-05	0.000126	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	3.76e-05	0.000125	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TERT—adrenal gland cancer	3.72e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—EGFR—adrenal gland cancer	3.67e-05	0.000122	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—POMC—adrenal gland cancer	3.56e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—BAD—adrenal gland cancer	3.53e-05	0.000118	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—POMC—adrenal gland cancer	3.48e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—adrenal gland cancer	3.46e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—adrenal gland cancer	3.46e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—BAD—adrenal gland cancer	3.44e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—BRAF—adrenal gland cancer	3.44e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—EGFR—adrenal gland cancer	3.41e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—EGFR—adrenal gland cancer	3.41e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TERT—adrenal gland cancer	3.4e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PTGS2—adrenal gland cancer	3.39e-05	0.000113	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PTGS2—adrenal gland cancer	3.39e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—adrenal gland cancer	3.37e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—EGFR—adrenal gland cancer	3.33e-05	0.000111	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—RRM1—adrenal gland cancer	3.3e-05	0.00011	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SDHD—adrenal gland cancer	3.3e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CTNNB1—adrenal gland cancer	3.29e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—POMC—adrenal gland cancer	3.26e-05	0.000109	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—BAD—adrenal gland cancer	3.23e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—BRAF—adrenal gland cancer	3.22e-05	0.000107	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—POMC—adrenal gland cancer	3.17e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—EGFR—adrenal gland cancer	3.16e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—BRAF—adrenal gland cancer	3.13e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—EGFR—adrenal gland cancer	3.12e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—EGFR—adrenal gland cancer	3.12e-05	0.000104	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.11e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTGS2—adrenal gland cancer	3.1e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—adrenal gland cancer	3.08e-05	0.000103	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—EGFR—adrenal gland cancer	3.04e-05	0.000101	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CTNNB1—adrenal gland cancer	3.04e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CTNNB1—adrenal gland cancer	3.04e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—EGFR—adrenal gland cancer	3.03e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CTNNB1—adrenal gland cancer	3.01e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—POMC—adrenal gland cancer	2.98e-05	9.94e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	2.98e-05	9.93e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—BAD—adrenal gland cancer	2.96e-05	9.86e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—BRAF—adrenal gland cancer	2.94e-05	9.81e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—adrenal gland cancer	2.89e-05	9.64e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—adrenal gland cancer	2.86e-05	9.55e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—adrenal gland cancer	2.86e-05	9.55e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—EGFR—adrenal gland cancer	2.85e-05	9.51e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTGS2—adrenal gland cancer	2.84e-05	9.48e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CTNNB1—adrenal gland cancer	2.78e-05	9.26e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—POMC—adrenal gland cancer	2.73e-05	9.09e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—BRAF—adrenal gland cancer	2.69e-05	8.97e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—adrenal gland cancer	2.66e-05	8.85e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—adrenal gland cancer	2.62e-05	8.73e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—EGFR—adrenal gland cancer	2.61e-05	8.7e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EGFR—adrenal gland cancer	2.61e-05	8.69e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—adrenal gland cancer	2.55e-05	8.51e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.5e-05	8.34e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CTNNB1—adrenal gland cancer	2.48e-05	8.28e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MED12—adrenal gland cancer	2.46e-05	8.2e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EGFR—adrenal gland cancer	2.41e-05	8.02e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EGFR—adrenal gland cancer	2.41e-05	8.02e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EGFR—adrenal gland cancer	2.38e-05	7.95e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CTNNB1—adrenal gland cancer	2.33e-05	7.75e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CTNNB1—adrenal gland cancer	2.26e-05	7.54e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EGFR—adrenal gland cancer	2.2e-05	7.34e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CTNNB1—adrenal gland cancer	2.13e-05	7.09e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EGFR—adrenal gland cancer	1.97e-05	6.56e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CTNNB1—adrenal gland cancer	1.95e-05	6.49e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EGFR—adrenal gland cancer	1.84e-05	6.14e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.79e-05	5.98e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EGFR—adrenal gland cancer	1.79e-05	5.98e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGFR—adrenal gland cancer	1.68e-05	5.62e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—adrenal gland cancer	1.65e-05	5.51e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—adrenal gland cancer	1.55e-05	5.16e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGFR—adrenal gland cancer	1.54e-05	5.14e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—adrenal gland cancer	1.5e-05	5.02e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.45e-05	4.85e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—adrenal gland cancer	1.41e-05	4.72e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—adrenal gland cancer	1.29e-05	4.31e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—POMC—adrenal gland cancer	9.79e-06	3.27e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—adrenal gland cancer	7.81e-06	2.6e-05	CbGpPWpGaD
